In a letter to DGCI Dr GN Singh, Addition Director (Health) Dr SK Arora said it had come to the notice of the department that pure nicotine having potential addiction property if used unsupervised was available in markets as a drug in the form of gums and lozenges which were being sold at chemist shops over the counter without any prescription.
Besides motivation, counseling and behavioral therapy, a small percentage of moderate to severely addicted tobacco users may require these drugs as nicotine replacement therapy (NRT) under the direct supervision of a qualified doctor or counsellor.
Sale of these drugs over the counter without prescription promotes self therapy and malpractices and it may lead to merely shifting the person from one addiction to other, the letter read.
Moreover, the younger generation and minors who are not able to directly use tobacco products due to social or family fear may easily use it secretively, Arora said.
"This may adversely affect the health of our younger generations. Unsupervised NRT can lead to NRT overdose and may cause death in younger age group. It is worth mentioning that nicotine gums and lozenges in 2 mg strength are available on over the counter sale," he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
